Format

Send to

Choose Destination
Curr Allergy Asthma Rep. 2012 Feb;12(1):72-8. doi: 10.1007/s11882-011-0238-z.

ACE inhibitor-induced angioedema.

Author information

1
Department of Medicine, Penn State University, Hershey, PA 17033, USA. mvasekar@hmc.psu.edu

Abstract

Much has been written about hereditary angioedema (HAE) in recent literature; however, the prevalence of angiotensin-converting enzyme inhibitor-induced angioedema (ACEiIA) far exceeds that of HAE. Similarly, multiple therapies have been developed for HAE, yet no definitive therapy is available for ACEiIA. In this article, we discuss the mechanism, prevalence, pathophysiology, and management of ACEiIA, with focus on newer therapies recently approved for HAE and how they may be effective for ACEiIA.

PMID:
22127615
DOI:
10.1007/s11882-011-0238-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center